Clinical Trial Search

Primary: Magnetic Resonance Spectroscopy (MRS) Will Measure a Change in Cerebral Energy Function in Brain Tissue — .011; .007; .009; .006 Difference in metabolite amplitude

Primary: Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Metabolism (Standard Uptake Value Ratio) — -0.0514; -0.0667 SUVR

Primary: Mean in Cerebral Metabolic Rate of Acetoacetate Before or After 4 Days of Ketogenic Diet — 0.672; 4.83 µmol/100g/min

Primary: Responder and Remission Status (%), Based on the Depression Rating Scale Score — 36; 32 participants

Primary: Global Change in Brain Glucose Uptake — 30.3; 30.4 μmol/100 g/min

Primary: Change in Glutamate Concentration During a Visual Stimulus Measured by fMRS at Normoxia — 4 percentage of concentration (micromol/g)

Primary: MoCA (Montreal Cognitive Assessment) — 28.38; 20.22 score on a scale — p=<0.0001

Primary: Net Nondimensional Oxygen Cost — -34.13; -15.86; 1.07; -0.60 Percent change relative to baseline

Primary: Quantitative Measurement of [18F]FPIA Uptake Within the Cerebral Metastases of Treatment naïve Patients. — 1.54; 1.47; 1.48 SUV_max (kBq/L/kBq/g)

Primary: Cerebral Blood Flow Global — -2.2 ml/100g/min — p=.002

Primary: Global Brain Glucose PET Uptake — 34.9 umol/100 g/min

Primary: Аssessment of Attentiveness and Performance — 94.9; 71.2; 75; 68.15 seconds

Primary: Modulation of Levels of Total Haemoglobin — 1.9; 2.4; 1.2 µmol/L — p=>0.05

Primary: Oxygen Consumption During Walking — 11.25; 4.46 ml/kg/min

Primary: Short Term Change in Weight — 1.7; -0.76 Kilogram

Primary: Change in Cerebral Blood Flow (Baseline to Week 5) — 2.15 mm2/s

Primary: Number of Metabolites Elevated Relative to the Other Group. — 13; 9 Number of metabolites elevated

Primary: Change in Fat Consumption (During VeNS) — 50.23; 54.44 % of fat as metabolic substrate

Primary: Change in CBF From Baseline (Before Start of the Hemodialysis Study Session), at 20 Minutes, and at the End of the Hemodialysis Study Session, Measured by [15O]H2OPET-CT…

Primary: Brain Glycogen Turnover Rate — 0.31; 0.28 mg/kg/min

Primary: Mean Concentrations of Cerebral Energetic Metabolites in Geriatric BPD and Older Controls at Baseline — 4.35; 3.94; 3.23; 3.06 Integration Expressed as Arbitrary Unit

Primary: Brain Glucose Consumption — 27.9; 28.1 umol/100 g/min

Primary: Change in Brain Glucose Metabolism Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET) — -3.40; -1.07; -7.58; -3.09 SUVBSA2

Primary: Composite Neurological Outcome of Clinical Stroke or New Ischemic Brain Lesion on Diffusion Weighted MRI or Neurocognitive Dysfunction 4 to 6 Weeks After Surgery. — 79…

Primary: Correct Responses on Serial 7 Subtraction Task — 40.91; 42.57; 43.04; 42.13 Correct responses — p=0.05

Primary: We Measured the Change in Rate Constant of Creatine Kinase in Individuals With Bipolar Depression Treated With CoQ 10 as Compared With Age and Gender Matched Controls…

Primary: Regional Cerebral Blood Flow Values of the Brain Measured Using Pseudo-continuous Arterial Spin Labeling (pCASL) MRI. — 35.4 ml/100g/min

Primary: BOLD Signal Measured by Functional MRI Scan to Functional Connectivity Measured by fMRI

Primary: Number of Participants With Reduction in Spike-wave Fraction of the EEG Recording Time — 13 Participants

Primary: Ratio of Inorganic Phosphate (Pi) Over Phosphocreatine (PCr): Pi/PCr — 0.44; 0.43; 0.44; 0.42 ratio